Curr Top Microbiol Immunol (2017) 410:99126
Compounded versions are not FDA-approved and have not undergone the same rigorous testing for efficacy, safety, and quality
Explore the pros and cons of GLP-1 drugs in managing diabetes and obesity, balancing benefits like weight loss against side effects and costs
The optimal choice of treatment depends on various factors, such as the severity of dark skin and other relevant considerations
The FDA said it's received reports of adverse events after people took semaglutide that came from a compounding pharmacy
Such observations prompted the investigation into the potential metabolic benefits of GLP-1R and GCGR co-activation (114, 115), which led to the subsequent development of GLP-1R/GCGR co-agonists (73, 116) and, later, GIPR/GLP-1R/GCGR tri-agonists (117)